Cancelmi Daniel J 4

What Happened Daniel J. Cancelmi, a director of Acadia Healthcare Company, Inc. (ACHC), received a grant/award of 6,625 shares on March 12, 2026. The reported acquisition price is $0.00 (i.e., a compensation grant), so the filing shows $0 total paid. This is a compensation award rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-03-12; Filing date (Form 4): 2026-03-18.
• Transaction type/code: Award/Grant (A). Shares: 6,625; price per share reported: $0.00.
• Vesting: Per footnote F1, the shares vest in equal annual installments over 3 years beginning March 12, 2027.
• Shares owned after transaction: Not disclosed in this filing.
• Timeliness: The grant occurred 2026-03-12 and the Form 4 was filed 2026-03-18. Form 4s are normally due within 2 business days of the transaction, so this filing appears later than the typical deadline.
• No indication in the filing of a 10b5-1 plan, immediate sale (cashless exercise), or tax-withholding sale.

Context Stock awards to directors are a common form of compensation and do not necessarily indicate the director is buying stock with personal funds. Because these shares vest over time, the director only gains full ownership if he remains with the company through the vesting dates. For retail investors, grants are informational about compensation practices but are not the same signal as a market purchase by an insider.